RU-2309
RU-2309 is a synthetic compound that belongs to the class of chemical compounds known as steroids. It is primarily used in scientific research as a selective androgen receptor modulator (SARM).
Chemical Structure[edit]
RU-2309 is a steroidal compound, which means it is composed of a series of carbon atoms arranged in a specific structure. This structure is similar to the natural hormones produced by the body, such as testosterone and estrogen. The specific structure of RU-2309 allows it to bind to androgen receptors in the body, which can influence the body's metabolism, muscle growth, and bone density.
Pharmacological Action[edit]
As a selective androgen receptor modulator, RU-2309 has the ability to selectively bind to androgen receptors in the body. This means it can have specific effects on certain tissues, such as promoting muscle growth or bone density, without affecting other tissues. This selectivity makes RU-2309 a valuable tool in scientific research, particularly in the study of endocrine disorders and musculoskeletal diseases.
Research and Clinical Trials[edit]
RU-2309 is primarily used in scientific research and has not been approved for use in humans. However, it has been the subject of numerous clinical trials and studies. These studies have primarily focused on its potential use in the treatment of conditions such as osteoporosis, muscle wasting diseases, and certain types of cancer.
Safety and Side Effects[edit]
As with any synthetic compound, there are potential risks and side effects associated with the use of RU-2309. These can include endocrine disruption, liver damage, and cardiovascular disease. However, because RU-2309 is not approved for use in humans, these risks are primarily theoretical and based on animal studies.
See Also[edit]
-
RU-2309
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian

